<DOC>
	<DOCNO>NCT01685905</DOCNO>
	<brief_summary>The purpose study 1. compare positivity tuberculin skin test ( TST ) QuantiFERON-TB Gold ( QFT-G ) , determine level agreement two test patient rheumatic disease 2. evaluate difference occurrence active TB patient receive QFT-G TST compare receive TST detect Latent tuberculosis infection ( LTBI ) candidate TNF inhibitor .</brief_summary>
	<brief_title>The Usefulness Interferon-Î³ Release Assays Tuberculin Skin Test Detection Latent Tuberculosis Infection</brief_title>
	<detailed_description>Study Assessment 1 . The positive rate QFT-G TST screen test LTBI - The positive rate QFT-G TST analyze - Additional analysis perform accord type disease 2 . The agreement QFT-G TST screen test LTBI - The agreement QFT-G TST analyze patient rheumatic disease examine QFT-G TST - Additional analysis perform accord type disease 3 . The correlation occurrence active TB two test ( QFT-G TST ) - The analysis correlation occurrence active TB two test conduct patient experienced anti-TNF agent 3-1 . The occurrence active TB accordance result TST 3-2 . The occurrence active TB accordance result QFT-G 3-3 . The difference occurrence active TB patient perform QFT-G TST compare perform TST detect LTBI candidate TNF inhibitor ( pilot study ) .</detailed_description>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Tuberculosis</mesh_term>
	<mesh_term>Spondylitis</mesh_term>
	<mesh_term>Rheumatic Diseases</mesh_term>
	<mesh_term>Spondylitis , Ankylosing</mesh_term>
	<mesh_term>Latent Tuberculosis</mesh_term>
	<mesh_term>Collagen Diseases</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<mesh_term>Interferon-gamma</mesh_term>
	<criteria>patient rheumatic disease examine TST QFTG Hanyang university hospital 2004 2010</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>rheumatic disease , latent tuberculosis</keyword>
</DOC>